NCT04251143 Dresden Corneal Disease and Treatment Study
| NCT ID | NCT04251143 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Technische Universität Dresden |
| Condition | Corneal Ectasia |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2018-03-12 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2018-03-12 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is long-term follow up of patients with corneal diseases to analyze the quality of surgical interventions and diagnosis. Corneal ectasia, especially keratoconus, is a corneal disease that leads to an irreversible loss of visual acuity while the cornea becomes steeper, thinner and irregular. For these patients, surgical intervention (e.g. corneal cross-linking) is performed, in case of disease progression. Overall, a long-term follow up is needed to evaluate an early disease progression as well as corneal stability after surgical intervention.
Eligibility Criteria
Inclusion Criteria: * corneal disease * corneal ectasia Exclusion Criteria: * pregnancy * age under 18 years
Contact & Investigator
Frederik Raiskup, MD, PhD
STUDY DIRECTOR
Department of Ophthalmology; Medical Faculty Carl Gustav Carus, Techinal University Dresden
Frequently Asked Questions
Who can join the NCT04251143 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Corneal Ectasia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04251143 currently recruiting?
Yes, NCT04251143 is actively recruiting participants. Contact the research team at robert.herber@uniklinikum-dresden.de for enrollment information.
Where is the NCT04251143 trial being conducted?
This trial is being conducted at Dresden, Germany.
Who is sponsoring the NCT04251143 clinical trial?
NCT04251143 is sponsored by Technische Universität Dresden. The principal investigator is Frederik Raiskup, MD, PhD at Department of Ophthalmology; Medical Faculty Carl Gustav Carus, Techinal University Dresden. The trial plans to enroll 700 participants.